Research and Markets: Blood Banking and Blood Products - Global Market Perspective

DUBLIN--()--Research and Markets ( has announced the addition of the "Blood Banking and Blood Products - Global Market Perspective" report to their offering.

A spurt in new infections surfacing the world over remains a huge concern to the blood banking and blood products industry. Though awareness amongst consumers and health workers helped in reducing the intensity of infection, the industry is yet to free itself of various problems such as safety, and availability of quality blood. The awareness has also resulted in the implementation of stringent safety standards for both donors, and blood screening (blood) banks to be adhered to before any transfusion. Rigorous testing and screening procedures, along with the help of new technology have sufficiently reduced the threat of diseases being transmitted through transfusions. Though the overall situation has improved, instances of diseases spreading through blood transfusion are still common in the developing and underdeveloped countries. Awareness campaigns in these countries have also drawn flak, with only a few donors volunteering.

These and other market data and trends are presented in "Blood Banking and Blood Products: Global Market Perspective" by BizAcumen, Inc. This report is designed to be most comprehensive in geographic coverage and vertical market analyses.

Key Topics Covered:


  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Quantitative Techniques & Reporting Level


  • Healthcare Scares Propel the Market
  • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
  • World Blood Components and Plasma Market Analysis in Units


  • New Infections - A Continuous Threat
  • Safety and Availability: The Core Issues
  • Decontamination: A Viable Process
  • New Processes for Safer Blood Supply
  • Innovative Procedures Help Blood Conservation
  • Autologous Transfusion Strapping up for High Growth
  • Enzyme Converted Cells Set to Rule the Industry
  • Blood Unavailability: Substitutes to the Rescue
  • Transfusions: Hospitals Making Way for Others
  • Computer Identification Helps Patients
  • SARS: A Case of Mistaken Identity?
  • Pooling: Economical HIV Testing
  • Private Cord Blood Banking: Flying High Despite Opposition
  • Consolidation Whittles Down Number of Market Players
  • Automation of Blood Banking - Nearing the Efficiency Frontier?
  • Automated Instrumentation Taking the Front Seat
  • Plasma Market: Automation Making Inroads
  • The RBC Market - Slow to Catch Up
  • Automation of Testing - Yet to Mature
  • Automation to Suffice Shortage Problems
  • How Near to the Efficiency Frontier?


  • Blood Components and Plasma Products
  • Whole Blood & Cellular Components
  • WBCs
  • RBCs
  • Platelets
  • Plasma Fractions
  • Fresh Frozen Plasma 15 Albumin Fractions
  • Factor VIII
  • Factor IX and Factor IX Complex
  • Fibrin/Thrombin
  • Equipment, Blood Tests and Consumables
  • Automated Analyzers for Blood Analysis
  • Blood Tests
  • Consumables
  • Changing Role of Blood Banking Technology


  • Bloodless Surgery
  • Therapeutic Apheresis
  • Plasmapheresis
  • Plateletpheresis
  • Leukapheresis
  • Volume Expanders
  • Colloids 21 Albumin
  • Dextrans
  • Hydroxyethyl Starch
  • Crystalloids
  • Blood Growth Factor Therapies - Newer Alternatives to Transfusion


  • Immucor Snaps Up BioArray Solutions
  • Global Med Technologies Acquires Inlog
  • Gen-Probe to Acquire Innogenetics
  • ThermoGenesis Partners with GE Healthcare
  • ThermoGenesis Ties Up with University of California
  • Gambro Inks Preliminary Agreement with S.C.M S.r.l.
  • ITL Extends Agreement with American Red Cross
  • CSL Enters into Agreements with Héma- Québec and Canadian Blood Services
  • Gambro Launches Bloodline Manufacturing Plant in Czech Republic
  • Global Med Technologies Inks an Agreement with FBC
  • VITA 34 and BKK Gruner + Jahr Sign Cooperation Agreement
  • Haemonetics Bags FDA Clearance for eLynx
  • Haemonetics Obtains FDA Approval for Symphony 2.0 Software
  • Thermogenesis Receives CE Mark Approval for Marrowxpress
  • Olympus PK 7300 Automated Microplate System Bags FDA Clearance
  • ABL80 FLEX CO-OX Blood Gas Analyzer Receives FDA Clearance
  • PK Blood Grouping and Phenotyping Reagents Get FDA Approval
  • Gambro BCT Changes its Name to Caridian BCT
  • Gen-Probe Introduces APTIMA HPV Assay
  • Olympus AU680 Analyzer Offers an Automated HbA1c Assay
  • Haemonetics Unveils New Plasma Collection Software
  • Haemonetics Acquires Infonalé
  • Terumo Acquires Salymed
  • Fresenius Takes Over Renal Solutions
  • PerkinElmer Completes ViaCell Acquisition
  • Inverness Medical Acquires HemoSense
  • Haemonetics Acquires Haemoscope' Hemostasis Analyzer Business Unit
  • NxStage Medical Completes Medisystems Acquisition
  • CordLife Establishes Cord Blood Bank in Indonesia
  • Cord Blood America Acquires Curesource
  • Fresenius Kabi Signs Agreement to Acquire Kyorin Pharmaceutical
  • Immucor and American Red Cross Ink Supply Agreement
  • Haemonetics Signs Contract with Octapharma
  • Immucor Obtains Clearance from FDA for Marketing Galileo Echo
  • Novartis Receives Approval for PROCLEIX TIGRIS System
  • Thermogenesis Obtains FDA Approval for Autoxpress
  • CSL Receives Approval for Rhophylac


  • AABB (USA)
  • America's Blood Centers (USA)
  • American Red Cross (USA)
  • Canadian Blood Services (Canada)
  • CorCell Companies Inc. (USA)
  • Cord Blood Registry (USA)
  • Japan Red Cross (Japan)
  • Lifebank Corp. (Canada)
  • National Blood Foundation (USA)
  • New England Cord Blood Bank, Inc. (USA)
  • New York Blood Center (USA)
  • VITA 34 AG (Germany)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • BioMerieux SA (France)
  • Caridian BCT, Inc (USA)
  • Chiron (USA)
  • CSL Behring LLC (USA)
  • Daxor Corporation (USA)
  • Fenwal Inc., (USA)
  • Fresenius SE (Germany)
  • Gambro AB (Sweden)
  • Gen-Probe Incorporated (USA)
  • Haemonetics Corp., (USA)
  • Hemagen Diagnostics Inc. (USA)
  • Immucor Inc. (USA)
  • Kawasumi Laboratories, Inc. (Japan)
  • Olympus America, Inc. (USA)
  • PharmaStem Therapeutics, Inc. (USA)
  • Terumo Corporation (Japan)
  • ThermoGenesis Corp. (USA)
  • ZymeQuest, Inc. (USA)
  • Baxter International Inc. (USA)
  • Bio Products Laboratory (UK)
  • CSL Limited (Australia)
  • CSL Bioplasma (Australia)
  • Grifols (Spain)
  • Kedrion (Italy)
  • Laboratoire Français du Fractionnement et des Biotechnologies (France)
  • Octapharma (Switzerland)
  • Sanquin (The Netherlands)
  • Talecris Biotherapeutics (USA)




For more information visit


Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716